Ringdén O - Search Results

1

Graft-versus-leukemia effect in allogeneic marrow transplant recipients with acute leukemia is maintained using cyclosporin A combined with methotrexate as prophylaxis. Acute Leukemia Working Party of the European Group for Blood and Marrow Transplantation.

Ringdén O, Labopin M, Gluckman E, Reiffers J, Vernant JP, Jouet JP, Harrousseau JL, Fiere D, Bacigalupo A, Frassoni F, Gorin NC. Ringdén O, et al. Bone Marrow Transplant. 1996 Nov;18(5):921-9. Bone Marrow Transplant. 1996. PMID: 8932846

2

Allogeneic bone marrow transplantation: the Huddinge experience.

Ringdén O. Ringdén O. Transplant Proc. 1992 Feb;24(1):371-3. Transplant Proc. 1992. PMID: 1311477 No abstract available.

3

Strong donor mononuclear cell reactivity for herpes simplex virus antigen in immune donor/recipient pairs is associated with acute graft-versus-host disease.

Boström L, Ringdén O, Forsgren M. Boström L, et al. Among authors: ringden o. Transplant Proc. 1992 Feb;24(1):376-7. Transplant Proc. 1992. PMID: 1311478 No abstract available.

4

Correlation of pretransplant viral serology and complications of bone marrow transplantation.

Ringdén O. Ringdén O. Ann Hematol. 1992 Jun;64 Suppl:A143-7. doi: 10.1007/BF01715369. Ann Hematol. 1992. PMID: 1322186 Review.

5

Prevention and therapy of graft-versus-host disease. Report from a work-shop.

Ringdén O, Kersey JH. Ringdén O, et al. Bone Marrow Transplant. 1992;10 Suppl 1:22-4. Bone Marrow Transplant. 1992. PMID: 1355684 No abstract available.

6

Oral and nutritional status in allogeneic marrow recipients treated with T-cell depletion or cyclosporine combined with methotrexate to prevent graft-versus-host disease.

Mattsson T, Heimdahl A, Dahllöf G, Lönnquist B, Ringdén O. Mattsson T, et al. Among authors: ringden o. Oral Surg Oral Med Oral Pathol. 1992 Jul;74(1):34-40. doi: 10.1016/0030-4220(92)90212-9. Oral Surg Oral Med Oral Pathol. 1992. PMID: 1508507

7

Blood transfusion in marrow graft recipients.

Pihlstedt P, Paulin T, Sundberg B, Nilsson B, Ringdén O. Pihlstedt P, et al. Among authors: ringden o. Ann Hematol. 1992 Aug;65(2):66-70. doi: 10.1007/BF01698131. Ann Hematol. 1992. PMID: 1511059

8

No association between splenomegaly and acute graft-vs.-host disease in humans after allogeneic bone marrow transplantation.

Boström L, Ringdén O. Boström L, et al. Among authors: ringden o. Transplant Proc. 1992 Feb;24(1):374-5. Transplant Proc. 1992. PMID: 1539323 No abstract available.

9

Immune response to Candida before and 5 years after allogeneic bone marrow transplantation.

Tollemar J, Sundberg B, Markling L, Ringdén O. Tollemar J, et al. Among authors: ringden o. Transplant Proc. 1992 Feb;24(1):378-9. Transplant Proc. 1992. PMID: 1539324 No abstract available.

10

Decreased incidence of graft-versus-host disease and improved survival with methotrexate combined with cyclosporin compared with monotherapy in recipients of bone marrow from donors other than HLA identical siblings.

Ringdén O, Klaesson S, Sundberg B, Ljungman P, Lönnqvist B, Persson U. Ringdén O, et al. Bone Marrow Transplant. 1992 Jan;9(1):19-25. Bone Marrow Transplant. 1992. PMID: 1543946

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

763 results

Search Page